Valuation: NeoGenomics, Inc.

Market Cap 1.97B 1.8B 1.66B 1.5B 2.83B 184B 2.94B 20.03B 7.93B 99.56B 7.4B 7.25B 314B P/E 2026 *
-63.9x
P/E 2027 * -58.4x
Enterprise Value 1.97B 1.8B 1.66B 1.5B 2.83B 184B 2.94B 20.03B 7.93B 99.56B 7.4B 7.25B 314B EV / Sales 2026 *
2.44x
EV / Sales 2027 * 2.22x
Free-Float
95.56%
Yield 2026 *
-
Yield 2027 * -
1 day+0.26%
1 week-9.15%
Current month-12.03%
1 month-8.17%
3 months-3.84%
6 months+82.68%
Current year+30.02%
1 week 14.86
Extreme 14.86
16.5
1 month 14.86
Extreme 14.86
18.15
Current year 7.06
Extreme 7.065
20.15
1 year 7.06
Extreme 7.065
20.15
3 years 4.72
Extreme 4.72
21.22
5 years 4.72
Extreme 4.72
40.5
10 years 4.72
Extreme 4.72
61.57
Manager TitleAgeSince
Chief Executive Officer 65 01/04/2025
Director of Finance/CFO 57 02/03/2026
President 54 01/04/2025
Director TitleAgeSince
Chairman 64 07/10/2021
Director/Board Member 63 19/07/2017
Director/Board Member 69 15/07/2020
Date Insider Type Main position Quantity % Market Cap. Importance
01/10/26 Exercice

Chairperson

42,035 0.0327%
01/09/26 Tax

General Counsel

-2,692 0.0021%
21/08/26 Exercice

Chairperson

67,272 0.0524%
Change 5-day change 1-year change 3-year change Capi.($)
+0.26%-9.15%+46.88%-21.23% 1.97B
-5.20%-9.13%+4.38%+18.22% 110B
-4.96%-5.87%-0.37%+93.34% 105B
+0.71%-9.48%+35.50%+440.92% 41.68B
-0.73%-0.21%+9.23%+95.31% 33.35B
+0.69%-0.39%+42.71%+75.13% 29.9B
+1.30%+0.39%+40.13%+92.52% 28.2B
-3.80%-7.38%+40.59%+325.70% 22.45B
-1.37%-2.56%-18.66%-20.58% 19.79B
-0.50%+2.46%-3.41%+33.11% 17.18B
Average -1.36%-2.88%+19.70%+113.24% 41B
Weighted average by Cap. -2.81%-2.38%+12.75%+111.53%

Financials

2026 *2027 *
Net sales 808M 736M 682M 615M 1.16B 75.53B 1.2B 8.2B 3.25B 40.78B 3.03B 2.97B 129B 887M 808M 748M 675M 1.27B 82.89B 1.32B 9B 3.56B 44.75B 3.33B 3.26B 141B
Net income -31.2M -28.43M -26.31M -23.73M -44.71M -2.92B -46.47M -317M -125M -1.57B -117M -115M -4.97B -34.24M -31.21M -28.88M -26.05M -49.08M -3.2B -51.01M -348M -138M -1.73B -128M -126M -5.46B
Net Debt - -
Projected Income Statement - Annual - NeoGenomics, Inc.
Logo NeoGenomics, Inc.
NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing, interpretation and consultative services, molecular and NGS testing, comprehensive technical and professional services offering, clinical trials and research, validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics, Fluorescence In-Situ Hybridization (FISH), Flow cytometry, Molecular testing and others.
Employees
2,500
Date Price Change Volume
18/11/26 $15.29 +0.26% 1,090,779
17/11/26 $15.25 -1.04% 1,033,367
16/11/26 $15.41 -3.81% 1,174,094
13/11/26 $16.02 -3.14% 2,217,575
12/11/26 $16.54 -1.72% 1,353,309
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
MarketScreener Ratings - NeoGenomics, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
15.25USD
Average target price
23.40USD
Spread / Average Target
+53.44%